EUVIMEDEUVIMED entdecken
Open Access

A glucan-particle based tularemia subunit vaccine induces T-cell immunity and affords partial protection in an inhalation rat infection model

Adam O Whelan iD, Helen C Flick-Smith, Nicola J Walker, Ambily Abraham, Stuart M Levitz iD, Gary R Ostroff, Petra C F Oyston

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0294998 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Adam O Whelan und 6 weiteren Autor:innen. Beteiligte Einrichtung: CBR Division, Dstl Porton Down, Salisbury, United Kingdom. Hauptthemen laut MEDLINE: Tularemia, Bacterial Vaccines, Francisella tularensis, Rats, Inbred F344. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, Defense Threat Reduction Agency, National Institute of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tularemia is a zoonotic disease caused by the facultative intracellular gram-negative bacterium Francisella tularensis . F . tularensis has a very low infection dose by the aerosol route which can result in an acute, and potentially lethal, infection in humans. Consequently, it is classified as a Category A bioterrorism agent by the US Centers for Disease Control (CDC) and is a pathogen of concern for the International Biodefence community. There are currently no licenced tularemia vaccines. In this study we report on the continued assessment of a tularemia subunit vaccine utilising β-glucan particles (GPs) as a vaccine delivery platform for immunogenic F . tularensis antigens. Using a Fischer 344 rat infection model, we demonstrate that a GP based vaccine comprising the F . tularensis lipopolysaccharide antigen together with the protein antigen FTT0814 provided partial protection of F344 rats against an aerosol challenge with a high virulence strain of F . tularensis , SCHU S4. Inclusion of imiquimod as an adjuvant failed to enhance protective efficacy. Moreover, the level of protection afforded was dependant on the challenge dose. Immunological characterisation of this vaccine demonstrated that it induced strong antibody immunoglobulin responses to both polysaccharide and protein antigens. Furthermore, we demonstrate that the FTT0814 component of the GP vaccine primed CD4 + and CD8 + T-cells from immunised F344 rats to express interferon-γ, and CD4 + cells to express interleukin-17, in an antigen specific manner. These data demonstrate the development potential of this tularemia subunit vaccine and builds on a body of work highlighting GPs as a promising vaccine platform for difficult to treat pathogens including those of concern to the bio-defence community.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TularemiaBacterial VaccinesFrancisella tularensisRats, Inbred F344Vaccines, SubunitDisease Models, AnimalAnimalsRatsGlucansT-LymphocytesFemaleAntigens, Bacterial

Substanzen

Bacterial VaccinesVaccines, SubunitGlucansAntigens, Bacterial

Autor:innen und Institutionen

  • CBR Division, Dstl Porton Down, Salisbury, United Kingdom.
  • University of Massachusetts Chan Medical School, Worcester, Massachusetts, United States of America.

ORCID-Profile: Adam O Whelan, Stuart M Levitz

Förderung

  • NIAID NIH HHS
  • Defense Threat Reduction Agency
  • National Institute of Health
  • National Institutes of Health

Zitieren

APA

Whelan, A. O., Flick-Smith, H. C., Walker, N. J., Abraham, A., Levitz, S. M., Ostroff, G. R., & Oyston, P. C. F. (2024). A glucan-particle based tularemia subunit vaccine induces T-cell immunity and affords partial protection in an inhalation rat infection model. PLOS ONE. https://doi.org/10.1371/journal.pone.0294998

Vancouver

Whelan AO, Flick-Smith HC, Walker NJ, Abraham A, Levitz SM, Ostroff GR, et al. A glucan-particle based tularemia subunit vaccine induces T-cell immunity and affords partial protection in an inhalation rat infection model. PLOS ONE. 2024. doi:10.1371/journal.pone.0294998

BibTeX
@article{Whelan2024,
  author = {Whelan, Adam O and Flick-Smith, Helen C and Walker, Nicola J and Abraham, Ambily and Levitz, Stuart M and Ostroff, Gary R and Oyston, Petra C F},
  title = {A glucan-particle based tularemia subunit vaccine induces T-cell immunity and affords partial protection in an inhalation rat infection model},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0294998}
}
Kostenlos starten →